SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000921895-18-003367
Filing Date
2018-12-21
Accepted
2018-12-21 15:30:35
Documents
6
Period of Report
2018-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k11577001_12212018.htm 8-K 27726
2 ex41to8k11577001_122118.htm EX-4.1 88271
3 ex42to8k11577001_122118.htm EX-4.2 86309
4 ex101to8k11577001_122118.htm EX-10.1 194952
5 ex102to8k11577001_122118.htm EX-10.2 98260
6 ex991to8k11577001_122118.htm EX-99.1 10539
  Complete submission text file 0000921895-18-003367.txt   507483
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 181249324
SIC: 2834 Pharmaceutical Preparations